NCT03846219Phase 2Active not recruiting

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Study sponsor: Immunic AG

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-04-24Actual
Enrollment · participants210Actual
Source updated2024-04-24Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.